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lism of amino acids are profoundly altered in patients
with liver disease, which results in an imbalanced amino
acid composition of the blood characterized by low lev-
els of glutamate, branched-chain amino acids (BCAA),
e.g., valine, isoleucine and leucine, while the concentra-
tions of most other amino acids are elevated. This dis-
turbance in protein and amino acid metabolism
decreases both the clearance of toxic metabolites and
the protein synthesis, which often results in a negative
nitrogen balance. The prevalence of protein–energy mal-
nutrition in patients with cirrhosis is high-reaching as
much as 60–90%, depending upon the severity and etiol-
ogy of the disease [1]. By now it is also evident that the
incidence of complications, that often end up with the
development of hepatic encephalopathy and multiorgan
dysfunction increases with malnutrition in patients with
chronic liver disease [1].
Because cirrhosis is associated with insulin resistance
and altered fuel substrate utilization the changes in the
BCAA composition are of interest as ingested BCAA,
which may escape metabolism can be used simply as fuel
substrates (as they do not need the intermediate step of
conversion to glucose) by an increased oxidation of
BCAA. Although the metabolism of the three BCAA
result in diﬀerent products, the initial steps in their0168-8278/$34.00  2008 European Association for the Study of the Liver.
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ched chain 2-oxoacid dehydrogenase.metabolism are similar. The activity of the BCAA ami-
notransferase, that exists in three isozymes, result in
three 2-oxoacids that all are oxidatively decarboxylated
by an inner mitocondrial membrane enzyme complex,
i.e., the branched-chain 2-oxoacid dehydrogenase
(BCOD). This event produces NADH and CO2and is
the rate-limiting step in BCAA oxidation. The resulting
CoA compounds are next acted on by an enzyme that
resemples the ﬁrst dehydrogenase of fatty acid b-oxida-
tion and ends up in the Krebs-cycle for energy produc-
tion. Under conditions with low levels of BCAA the
BCOD complex activity is suppressed [2] preserving as
much BCAA as possible for protein synthesis. As men-
tioned before the BCAA in patients with chronic liver
disease is reduced and the activity of the BCOD complex
could be expected to be low, at least under stable,
uncomplicated conditions.
Unfortunately complications often occur in patients
with cirrhosis with development of hemodynamic insta-
bility with tissue hypoperfusion. Especially episodes of
upper GI bleeding, a common complication in cirrhotic
patients has been shown to further imbalance the
plasma amino acids composition. Indeed, variceal bleed-
ing is well known to be an important initial trigger event
for acute deterioration in patients with cirrhosis with
development of hepatic encephalopathy and renal fail-
ure, which cannot solely be explained by the hemody-
namic instability this causes.
Dr. Olde Damink and colleagues have previously
suggested that another explanation may be of impor-
tance due to the fact that ingested blood contains only
small amounts of isoleucine, while the concentration of
the two other BCAA, i.e., leucine and valine are several-
fold higher [3]. In other words, an upper GI bleed fromPublished by Elsevier B.V. All rights reserved.
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leucine, while most of the other amino acids increase. So
the question arises if an isolated decrease in the isoleu-
cine concentration together with an increase in that of
leucine (and valine) may cause problems that calls for
closer clinical attention? To answer this question it
may be of value ﬁrst to recall the concept of BCAA
antagonism, as this is the focus in another important
paper by Dr. Olde Damink in this issue of Journal of
Hepatology [4].
Harper et al. [5] showed already in 1954 that feeding
with a low-protein diet with excess of leucin prevents
growth in rats. This was not the case when leucine was
added to a diet less restricted in protein or when the
low-protein diet was added isoleucine and valine, which
suggested that leucine interfere with growth through
mechanisms causing a defective utilization of BCAA.
In the following years subsequent studies showed that
leucine decreases the concentrations of valine and isoleu-
cine because excess dietary leucine causes accelerated
catabolism of these amino acids. The reason for this
excess ‘‘use” of valine and isoleucine during a high
plasma leucine concentration has until now been unclear,
but is here hypothesized [4] to simply rely on the fact that
all BCAA share the same transport and degradation
pathways that’s include the BCOD. In other words an
isolated elevated leucine concentration may induce oxi-
dation of all the BCAA’s via activation of the BCOD
complex even if the plasma and tissue concentration of
isoleucine and valine are already subnormal. In this con-
text, the paper in this issue of Journal of Hepatology by
Dr. Steven Olde Damink et al. [4] is a particularly timely
publication, where they simulated an upper GI bleed in a
non-randomised, controlled, design that included only
ﬁve patients with stable, compensated cirrhosis. The
aim of this elegant study [4] was to determine the isoleu-
cine turnover and oxidation, using state-of-the-art tech-
niques both during an intragastric placebo infusion
(i.e., saline) and during administration of an amino acid
solution mimicking hemoglobin.
The obtained data show that the studied patients
developed profound hypoisoleucinemia, and that the
whole body isoleucine ﬂux decreased by 70% duringexposure to such a simulated upper GI bleed. Since, iso-
leucine oxidation and the non-oxidative fraction of iso-
leucine ﬂux decreased similarly this indicates, as also
concluded by the authors [4], that the rate of protein
synthesis decreases. At the same time the fraction of iso-
leucine ﬂux used for oxidation did not decrease, which
indicates that an upper GI bleed in patients with cirrho-
sis induces BCAA antagonism, and the authors suggest
that the resulting hypoisoleucinemia is of pathophysio-
logical importance for complications such as muscle
waste, malnutrition, recurrent infections, renal failure,
and hepatic encephalopathy.
If BCAA antagonism is induced in patients with cir-
rhosis complicated by variceal bleeding what can we
then possibly do to counteract the imminent complica-
tions that follow? An interesting possibility here [4] and
previously [3] suggested by the authors is to initiate i.v.
infusion of isoleucine to help correct the imbalanced
BCAA composition and thereby prevent catabolism,
hepatic encephalopathy and other complications [3].
Though so simple and appealing in theory, the data
and conclusions here presented will likely require a
considerable amount of resources (and hard work), to
be demonstrated in large cohort of cardiovascular
unstable cirrhotic patients experiencing a real upper
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